A detailed history of Td Private Client Wealth LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 71 shares of BIO stock, worth $23,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 72 1.39%
Holding current value
$23,862
Previous $19.7 Million 20.8%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$263.97 - $344.64 $263 - $344
-1 Reduced 1.39%
71 $23.8 Million
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $19,314 - $24,442
72 New
72 $19.7 Million
Q1 2024

Aug 16, 2024

SELL
$304.11 - $351.99 $194,934 - $225,625
-641 Reduced 82.71%
134 $46.3 Million
Q4 2023

Aug 16, 2024

SELL
$269.37 - $365.04 $582,647 - $789,581
-2,163 Reduced 73.62%
775 $250 Million
Q3 2023

Aug 16, 2024

SELL
$350.25 - $422.63 $16,812 - $20,286
-48 Reduced 1.61%
2,938 $1.05 Billion
Q2 2023

Aug 16, 2024

BUY
$359.49 - $486.4 $10,425 - $14,105
29 Added 0.98%
2,986 $1.13 Billion
Q1 2023

Aug 16, 2024

BUY
$418.69 - $503.0 $118,070 - $141,846
282 Added 10.54%
2,957 $1.42 Billion
Q4 2022

Aug 16, 2024

BUY
$351.71 - $456.01 $71,397 - $92,570
203 Added 8.21%
2,675 $1.12 Billion
Q3 2022

Aug 16, 2024

BUY
$412.59 - $563.26 $83,343 - $113,778
202 Added 8.9%
2,472 $1.03 Billion
Q2 2022

Aug 16, 2024

BUY
$463.67 - $597.16 $37,557 - $48,369
81 Added 3.7%
2,270 $1.12 Billion
Q1 2022

Aug 16, 2024

BUY
$524.57 - $735.42 $168,911 - $236,805
322 Added 17.25%
2,189 $1.23 Billion
Q4 2021

Aug 16, 2024

SELL
$708.84 - $794.68 $264,397 - $296,415
-373 Reduced 16.65%
1,867 $1.41 Billion
Q3 2021

Aug 16, 2024

BUY
$657.71 - $825.77 $1.43 Million - $1.79 Million
2,168 Added 3011.11%
2,240 $1.67 Billion
Q2 2021

Aug 16, 2024

BUY
$576.64 - $649.04 $13,262 - $14,927
23 Added 1.08%
2,155 $1.39 Billion
Q1 2021

Aug 16, 2024

BUY
$547.01 - $662.35 $244,513 - $296,070
447 Added 26.53%
2,132 $1.22 Billion
Q4 2020

Aug 16, 2024

SELL
$510.68 - $643.45 $122,052 - $153,784
-239 Reduced 12.42%
1,685 $982 Million
Q3 2020

Aug 16, 2024

SELL
$454.43 - $535.6 $11,815 - $13,925
-26 Reduced 1.33%
1,924 $992 Million
Q2 2020

Aug 16, 2024

BUY
$334.87 - $493.06 $232,734 - $342,676
695 Added 55.38%
1,950 $880 Million
Q1 2020

Aug 16, 2024

BUY
$320.01 - $409.07 $87,042 - $111,267
272 Added 27.67%
1,255 $440 Million
Q4 2019

Aug 16, 2024

BUY
$319.73 - $374.2 $291,274 - $340,896
911 Added 1265.28%
983 $364 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.28B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.